Sunday, Exelixis Inc (NASDAQ: EXEL) provided financial guidance for fiscal year 2024 and delivered an update on its business. The company announced preliminary FY23 revenue of $1.83 billion versus the consensus of $1.84 billion, with net product revenues of ~ $1.630 billion. For FY24, Exelixis forecasts revenues of $1.825 billion – $1.925 billion versus the consensus of $2.06 billion. Exelixis authorized a $450 million share repurchase in 2024 after the $550 million share repurchase was completed in 2023. The company announced corporate restructuring, resulting in a workforce reduction of appr…